medigraphic.com
ISSN 0016-3813 (Impreso)

2008, Número 4

<< Anterior Siguiente >>

Gac Med Mex 2008; 144 (4)


Colonización por Staphylococcus aureusy riesgo de desarrollar episodio de peritonitiscausado por cepa idéntica en pacientes pediátricosen diálisis peritoneal continua ambulatoria

Miranda-Novales G, Aburto y-Huesca R, Leaños-Miranda B, Mendoza-Guevara L, Paniagua R, Amato D

Idioma: Español
Referencias bibliográficas: 35
Paginas: 297-302
Archivo PDF: 124.35 Kb.


RESUMEN

Objetivo: Determinar el riesgo de los pacientes pediátricos con insuficiencia renal crónica terminal en programa de diálisis peritoneal continua ambulatoria (DPCA), portadores de Staphylococcus aureus (SA) en nariz, manos o sitio de salida del catéter, para desarrollar episodio de peritonitis causado por una cepa idéntica.
Métodos: Estudio longitudinal en un centro de DPCA perteneciente a un hospital pediátrico de tercer nivel. Al ingresar al estudio se tomaron cultivos de las narinas, sitio de salida del catéter y manos, de 29 pacientes vigilados por un periodo promedio de 369 ± 80 días (de 224 a 516 días), y de las narinas y manos de sus madres. Las cepas de SA aisladas se conservaron en glicerol BHI a –20°C para análisis posterior. Los episodios de peritonitis se monitorearon y registraron. Cuando se aisló una cepa de SA del líquido de diálisis efluente se comparó con la previa identificada por electroforesis en gel de campos pulsados.
Resultados: Se presentaron siete episodios de peritonitis causados por SA en seis pacientes, uno de los cuales era portador previo de la misma cepa en la nariz y dos en el sitio de salida del catéter. El riesgo relativo de desarrollar un episodio de peritonitis causado por una cepa preexistente localizada en el sitio de salida del catéter fue de 0.948, y de 0.525 por una cepa preexistente localizada en la nariz.
Conclusiones: Los portadores de SA no parecen tener riesgo más alto de desarrollar peritonitis causada por una cepa de SA relacionada que los no portadores. No se sustenta la recomendación de monitorear el estado de portador nasal o en el sitio de salida del catéter en los pacientes tratados con DPCA. La conveniencia de erradicar el SA de la nariz o el sitio de salida del catéter también es cuestionable.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Alexander SR, Honda M. Continuous peritoneal dialysis for children: a decade of worldwide growth and development. Kidney Int 1993;40:S65-S74.

  2. Yinnon AM, Gabay D, Raveh D, Schlesinger Y, Slotki I, Attias D, et al. Comparison of peritoneal fluid culture results from adults and children undergoing CAPD. Perit Dial Int 1999;19:51-55.

  3. Monteón F, Correa-Rotter R, Paniagua R, Amato D, Hurtado ME, Medina JL, Medina JL. Prevention of peritonitis with disconnect systems in CAPD: a randomized controlled trial. Kidney Int 1998;54:2123-2128.

  4. Daly CD, Campbell MK, MacLeod AM, Cody DJ, Vale LD, Grant AM, et al. Do the Y-set and double-bag systems reduce the incidence of CAPD peritonitis? A systematic review of randomized controlled trials. Nephrol Dial Transplant 2001;16:341-347.

  5. Stablein DM, Sullivan EK, Donaldson LA. North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). The 1999 Annual Report. Potomac Md: The Emmes Corporation; 1999.

  6. Li PK, Szeto CC, Law MC, Chau KF, Fung KS, Leung CB, et al. Comparison of double-bag and Y-set disconnect systems in continuous ambulatory peritoneal dialysis: a randomized prospective multicenter study. Am J Kidney Dis 1999;33:535-540.

  7. Monsen T, Olofsson C, Rönnmark M, Wiström J. Clonal spread of staphylococci among patients with peritonitis associated with continuous ambulatory peritoneal dialysis. Kidney Int 2000;57:613-618.

  8. Amato D, Ventura MJ, Miranda G, Leaños B, Alcántara G, Hurtado ME, et al. Staphylococcal peritonitis in continuous ambulatory peritoneal dialysis: colonization with identical strains at exit site, nose, and hands. Am J Kidney Dis 2001;37:43-48.

  9. Zimakoff J, Bangsgaard-Pedersen F, Bergen L, Baago-Nielsen J, Daldorph B, Espersen F, et al. Staphylococcus aureus carriage and infections among patients in four haemo- and peritoneal dialysis centres in Denmark. The Danish Study Group of Peritonitis in Dialysis (DASPID). J Hosp Infect 1996;33:289-300.

  10. Davies SG, Ogg CS, Cameron JS, Poston S, Noble WC. Staphylococcus aureus nasal carriage, exit site infection and catheter loss in patients treated with continuous ambulatory peritoneal dialysis (CAPD). Perit Dial Int 1989;9:61-64.

  11. Wanten GJ, van Oost P, Schneeberger PM, Koolen MI. Nasal carriage and peritonitis by Staphylococcus aureus in patients on continuous ambulatory peritoneal dialysis: a prospective study. Perit Dial Int 1996;16:352-356.

  12. Pignatari A, Pfaller M, Hollis R, Sesso R, Leme I, Herwaldt L. Staphylococcus aureus colonization and infection in patients on continuous ambulatory peritoneal dialysis. J Clin Microbiol 1990;28:1898-1902.

  13. Sesso R, Draibe S, Castelo A, Sato I, Leme I, Barbosa D, et al. Staphylococcus aureus skin carriage and development of peritonitis in patients on continuous ambulatory peritoneal dialysis. Clin Nephrol 1989;31:264-268.

  14. Beard-Pegler MA, Gabelish CL, Stubbs E, Harbour C, Robson J, Falk M, et al. Prevalence of peritonitis-associated coagulase-negative staphylococci on the skin of continuous ambulatory peritoneal dialysis patients. Epidemiol Infect 1989;102:365-378.

  15. Brown AL, Stephenson JR, Baker LR, Tabaqchali S. Epidemiology of CAPDassociated peritonitis caused by coagulase-negative staphylococci: comparison of strains isolated from hands, abdominal Tenchkoff catheter exit site and peritoneal fluid. Nephrol Dial Transplant 1991;6:643-648.

  16. Eisenberg ES, Ambalu M, Szylagi G, Aning V, Soeiro R. Colonization of skin and development of peritonitis due to coagulase-negative staphylococci in patients undergoing peritoneal dialysis. J Infect Dis 1987;156:478-482.

  17. Shlichting C, Branger C, Fournier JM, Witte W, Boutonnier A, Wolz C, et al. Typing of Staphylococcus aureus by pulse field gel electrophoresis, zymotyping, capsular typing and phage typing: resolution of clonal relationships. J Clin Microbiol 1993;31:227-232.

  18. Struelens M, Deplano A, Godard C, Maes N, Serruys E. Epidemiologic typing and delineation of genetic relatedness of methicillin-resistant Staphylococcus aureus by macrorestriction analysis of genomic DNA by using pulsed-field gel electrophoresis. J Clin Microbiol 1992;30:2599-2605.

  19. Saulnier P, Bourneix C, Prevost G, Andremont A. Random amplified polymorphic DNA assay is less discriminant than pulsed-field gel electrophoresis for typing strains of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 1993;31:982-985.

  20. Chang HR, Lian JD, Shu KH, Cheng CH, Wu MJ, Chen CH, et al. Use of pulsed-field gel electrophoresis in the analysis of recurrent Staphylococcus aureus infections in patients on continuous ambulatory peritoneal dialysis. Am J Nephrol 2000;20:463-467.

  21. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: Criteria for bacterial strain typing. J Clin Microbiol 1995;33:2233-2239.

  22. Twardowski ZJ, Prowant BF. Staphylococcus aureus nasal carriage is not associated with increased incidence of exit-site infection with the same organism. Perit Dial Int 1993;13(Suppl 2):S306-S309.

  23. Lubrich-Birkner I, Schollmeyer P, Bohler J. Carrier-status for nasal staphylococci does not predict infections in CAPD patients. Adv Perit Dial 1994;10:154-157.

  24. Ritzau J, Hoffman RM, Tzamaloukas AH. Effect of preventing Staphylococcus aureus carriage on rates of peritoneal catheter-related staphylococcal infections. Literature synthesis. Perit Dial Int 2001;21:471-479.

  25. Pratt O. An integrated critique of the efficacy of topical mupirocin in preventing catheter-related staphylococcal infections in peritoneal dialysis clients. CANNT J 2002;12:20-28.

  26. Watson AR, Gartland C, on Behalf of the European Paediatric Peritoneal Dialysis Working Group. Guidelines by an ad hoc European Committee for elective chronic peritoneal dialysis in pediatric patients. Perit Dial Int 2001;21:240-244.

  27. Piraino B, Perlmutter JA, Holley JL, Bernardini J. Staphylococcus aureus peritonitis is associated with Staphylococcus aureus nasal carriage in peritoneal dialysis patients. Perit Dial Int 1993;13(suppl 2):S332-S334.

  28. Mupirocin Study Group. Nasal mupirocin prevents Staphylococcus aureus exitsite infection during peritoneal dialysis. J Am Soc Nephrol 1996 ;7 :2403-2408.

  29. Zimmerman SW, Ahrens E, Johnson CA, Craig W, Leggett J, O’Brien M, et al. Randomized controlled trial of prophylactic rifampin for peritoneal dialysisrelated infections. Am J Kidney Dis 1991;18:225-231.

  30. Annigeri R, Conly J, Vas SI, Dedier H, Prakashan KP, Bargman JM, et al. Emergence of mupirocin-resistant Staphylococcus aureus in chronic peritoneal dialysis patients using mupirocin prophylaxis to prevent exit site infection. Perit Dial Int 2001;21:554-559.

  31. Oliveira DC, Tomasz A, de Lencastre H. Secrets of success of a human pathogen: Molecular evolution of pandemic clones of methicillin-resistant Staphylococcus aureus. Lancet Infect Dis 2002;2:180-189.

  32. Thodis E, Bhaskaran S, Pasadakis P, Bargman JM, Vas SI, Oreopoulos DG. Decrease in Staphylococcus aureus exit-site infections and peritonitis in CAPD patients by local application of mupirocin ointment at the catheter exit site. Perit Dial Int 1998;18:261-270.

  33. Waite NM, Webster N, Laurel M, Johnson M, Fong IW. The efficacy of exitsite povidone-iodine ointment in the prevention of early peritoneal dialysisrelated infections. Am J Kidney Dis 1997;29:763-768.

  34. Holloway M, Mujais S, Kandert M, Warady BA. Pediatric peritoneal dialysis training: Characteristics and impact on peritonitis rates. Perit Dial Int 2001;21:401-404.

  35. Blanc DS, Struelens MJ, Deplano A, De Ryck R, Hauser PM, Petignat C, et al. Epidemiological validation of pulsed-field gel electrophoresis patterns for methicillin resistant Staphylococcus aureus. J Clin Microbiol 2001;39:3442-3445.




2020     |     www.medigraphic.com